More Than 30 Companies Will Soon Make Generics of Pfizer's COVID-19 Pill — Nearly three dozen companies worldwide will soon start making generic versions of Pfizer’s coronavirus pill, the U.N.-backed Medicines Patent Pool that negotiated the deal said Thursday.
Generic drugmakers across a dozen countries in Asia, the Caribbean, the Middle East and Eastern Europe will begin producing either the raw ingredients for the Pfizer drug or the pill itself. Among the companies offered a license was one in Ukraine, which has not yet been able to confirm it can participate.
Gore estimated that some of the generic companies might be ready to submit their drugs for regulatory approval later this year, with some supplies available in 2023.has been found to cut the risk of hospitalization or death in people at risk of severe COVID-19 by up to 90%; it is also thought to be effective against the omicron variant because it does not target the coronavirus’ spike protein, where most of the worrying mutations are.
Good, now dissolve their patent for it. There is no such thing as 'intellectual property.'